Polymyalgia rheumatica Flashcards
Define polymyalgia rheumatica
An inflammatory condition of unknown cause, which is
characterised by severe bilateral pain and morning
stiffness of the shoulder, neck and pelvic girdle.
NOTE: polymyalgia rheumatica does NOT cause weakness
Explain the aetiology/risk factors of polymyalgia rheumatica
UNKNOWN
Genetic and environmental factors
Associations
Temporal Arteritis, 40-50% of people with temporal arteritis have polymyalgia rheumatica
15% of people with polymyalgia rheumatica will go on to develop temporal arteritis
Both conditions respond to corticosteroids
Summarise the epidemiology of polymyalgia rheumatica
Relatively common
Occurs in people aged > 50 yrs
Peak age of onset: 73 yrs
3 x more common in FEMALES
Recognise the presenting symptoms and signs of polymyalgia rheumatica
Tend to be relatively non-specific
Usual inclusion criteria for polymyalgia rheumatica:
Age > 50 yrs
Duration of symptoms > 2 weeks
Bilateral shoulder or pelvic girdle aching, or both
Morning stiffness lasting > 45 mins
High ESR/CRP
The characteristic clinical picture of polymyalgia rheumatica: bilateral shoulder pain and stiffness of acute or subacute onset with bilateral arm tenderness
NO WEAKNESS
Symptoms are worst when walking
Identify appropriate investigations for polymyalgia rheumatica
ESR/CRP - raised in polymyalgia rheumatica FBC U&Es LFTs Bone profile Protein electrophoresis TFTs Creatine kinase
Others: urinary Bence Jones proteins, autoantibodies (e.g. anti-CCP antibodies)
Generate a management plan for polymyalgia rheumatica
CORTICOSTEROIDS (Miracle cure, quick onset)
Steroid-sparing agents (e.g. methotrexate) are sometimes used
Assistance from physiotherapy and occupational therapy
Monitor for adverse effects of steroids (e.g. osteoporosis
Identify possible complications of polymyalgia rheumatica
Temporal arteritis
Relapse of disease
Complications of steroid use (e.g. fracture risk)
Summarise the prognosis for patients with polymyalgia rheumatica
15% risk of getting temporal arteritis
Variable course and prognosis
Usually responds rapidly to steroid treatment
Relapse is common